drugset
drugset / Trial / NCT00674115

A Pharmacodynamic Study Comparing Zegerid® and Prilosec OTC® (CL2007-17 )(P07813)(COMPLETED)

NCT00674115 ↗

Phase 3 Completed 60 enrolled Bayer Bausch Health Americas, Inc. · collab
RandomizedCrossoverOpen-label

Summary

Open-label randomized crossover design studies. 60 participants will be evaluated on Day 1 to compare effects on stomach acid; 30 participants will continue treatment for 7 days and will have repeat evaluations at Day 7. The other 30 participants will receive a single administration of sodium bicarbonate.

Timeline

Start
2008-04
Primary completion
2008-06
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Omeprazole Other / unclassified 20 mg Oral
Comparator sodium bicarbonate Diagnostic / imaging agent 1680 mg Oral

Indications

No indication recorded.